A genome-wide CRISPR/Cas9 screen identifies calreticulin as a selective repressor of ATF6α.
ATF6⍺
CHO-K1 cells
CRT
UPR
calreticulin
cell biology
endoplasmic reticulum
genome-wide CRISPR/Cas9 screen
unfolded protein response
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
29 Jul 2024
29 Jul 2024
Historique:
medline:
29
7
2024
pubmed:
29
7
2024
entrez:
29
7
2024
Statut:
epublish
Résumé
Activating transcription factor 6 (ATF6) is one of three endoplasmic reticulum (ER) transmembrane stress sensors that mediate the unfolded protein response (UPR). Despite its crucial role in long-term ER stress adaptation, regulation of ATF6 alpha (α) signalling remains poorly understood, possibly because its activation involves ER-to-Golgi and nuclear trafficking. Here, we generated an ATF6α/Inositol-requiring kinase 1 (IRE1) dual UPR reporter CHO-K1 cell line and performed an unbiased genome-wide CRISPR/Cas9 mutagenesis screen to systematically profile genetic factors that specifically contribute to ATF6α signalling in the presence and absence of ER stress. The screen identified both anticipated and new candidate genes that regulate ATF6α activation. Among these, calreticulin (CRT), a key ER luminal chaperone, selectively repressed ATF6α signalling: Cells lacking CRT constitutively activated a BiP::sfGFP ATF6α-dependent reporter, had higher BiP levels and an increased rate of trafficking and processing of ATF6α. Purified CRT interacted with the luminal domain of ATF6α
Identifiants
pubmed: 39073063
doi: 10.7554/eLife.96979
pii: 96979
doi:
pii:
Substances chimiques
Activating Transcription Factor 6
0
Calreticulin
0
ATF6 protein, human
0
Protein Serine-Threonine Kinases
EC 2.7.11.1
Banques de données
GEO
['GSE254745']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Wellcome Trust
ID : 10.35802/224407
Pays : United Kingdom
Informations de copyright
© 2024, Tung et al.
Déclaration de conflit d'intérêts
JT, LH, GG, HH, AO No competing interests declared, DR Reviewing editor, eLife